Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jatin Mistry"'
Autor:
Biren Jitendra Parikh, Anuradha Harish Chilani, Riya Chetankumar Nayak, Kartavya Jatin Mistry, Priya Pravinbhai Gediya, Khushi Biren Parikh
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 4, Pp 211-217 (2024)
Background: Gastrointestinal (GI) disorders are one of the most commonly encountered health problems in routine clinical practice. Dietary, environmental, geographic, and genetic factors are some of the key reasons contributing to the prevalence of t
Externí odkaz:
https://doaj.org/article/5e36e356c8f340b89e8a0eb451d21a9c
Autor:
Kartavya Jatin Mistry, Shilpa Krishnakant Patel, Krishnakant Hargovindbhai Patel, Monaben Nareshbhai Ladwa, Rupal Paresh Mehta
Publikováno v:
Asian Journal of Medical Sciences, Vol 14, Iss 10, Pp 246-250 (2023)
Background: Incidental gallbladder carcinoma (IGBC) refers to gallbladder cancer which is not suspected clinically or radiologically and is detected for the first time on histopathological examination (HPE). Aims and Objectives: To find the incide
Externí odkaz:
https://doaj.org/article/c2fce2ccce6b4bd9b30ee02e95774a08
Autor:
Shilpa Krishnakant Patel, Rupal Paresh Mehta, Anuradha Harish Chilani, Kartavya Jatin Mistry, Dhruvi Pareshbhai Pandya, Riya Chetankumar Nayak
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 02, Pp 06-11 (2024)
Introduction: Blood transfusion is a lifesaving intervention. However, it can also be a source of Transfusion-transmissible Infections (TTIs), posing a potential threat to the recipient. Testing for TTIs before blood transfusion is crucial for the sa
Externí odkaz:
https://doaj.org/article/add591ed115c4946af999419978f72d3
Publikováno v:
Rheumatology. 60
Background/Aims NICE publishes guidance underpinned by act of Parliament and legally enforceable, on the use of biological therapies in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) which should
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54169398b90d526c79d3b34285267e41
https://doi.org/10.1093/rheumatology/keab247.090
https://doi.org/10.1093/rheumatology/keab247.090
Autor:
Ailsa Bosworth, Jatin Mistry, Arvind Kaul, Xenofon Baraliakos, Annamaria Iagnocco, Iain McNicol
Publikováno v:
Rheumatology Advances in Practice
Objectives Advanced therapies (AT), including biologics, biosimilars and Janus kinase inhibitors, have dramatically improved the quality of life of patients with RA, PsA and axial spondyloarthritis (axSpA). Evidence-based criteria for prescribing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0fee20599415e710bdf2370faa3d8d
https://doi.org/10.1093/rap/rkab081
https://doi.org/10.1093/rap/rkab081
Autor:
Hamzah Farooq Niaz, Jatin Mistry
Publikováno v:
Medical teacher. 43(9)
The vast majority of clinical skills teaching at our medical school in London is delivered through a peer teaching programme, with research demonstrating that medical students unequivocally prefer being taught clinical skills by peer teachers (studen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a91b494a7a4ae68049bf6fcae26467b
https://pubmed.ncbi.nlm.nih.gov/33290661
https://pubmed.ncbi.nlm.nih.gov/33290661
Autor:
Philip A. Clarke, Michael W. Fay, Jatin Mistry, Phoebe McCrorie, A.A. Ritchie, Ian A. Ward, Stuart Smith, Vincenzo Taresco, Maria Marlow, Ruman Rahman, Tatiana Lovato
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 157
Glioblastoma is a malignant brain tumour with a median survival of 14.6 months from diagnosis. Despite maximal surgical resection and concurrent chemoradiotherapy, reoccurrence is inevitable. To try combating the disease at a stage of low residual tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3434accf8fc9f645a365ee5521f73b
https://pubmed.ncbi.nlm.nih.gov/33068736
https://pubmed.ncbi.nlm.nih.gov/33068736
Autor:
Amy Prideaux, Jatin Mistry, Malama Sumbwanyambe, Lewis Carpenter, Mohammed Sharif, Patrick D W Kiely, Catherine Smith, Margaret Sibley, Melissa Sweeney
Publikováno v:
Rheumatology Advances in Practice
Objective The aim was to assess how the patient-reported outcome RA impact of disease (RAID) relates to DAS28 categories in routine care, its utility in identifying patients in DAS28 remission (RDAS) or low disease activity (LDAS) and the burden of u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc07129faffc1d92859ce5f835cd49a
http://europepmc.org/articles/PMC7359769
http://europepmc.org/articles/PMC7359769
Publikováno v:
Rheumatology. 59
Background NICE guidance approves pathways for inflammatory arthritis biologic therapies. Locally, CCG's commission pathways based on their interpretation of NICE guidance. For patients to have equal access to biologics, CCG pathways in different are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e282db761744e9e55f03c005bfd0aa1
https://doi.org/10.1093/rheumatology/keaa111.085
https://doi.org/10.1093/rheumatology/keaa111.085
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background Biologic disease modifying anti-rheumatic drugs (bDMARD) are widely used in rheumatologic practice. Subcutaneous bDMARDs are licenced in a fixed dose for all indications (RA, PsA, AS) yet therapeutic drug monitoring (TDM) of TNF inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1484932d0993b268d02fcdfa0da9d0a9
https://doi.org/10.1136/annrheumdis-2019-eular.1750
https://doi.org/10.1136/annrheumdis-2019-eular.1750